Principal Financial Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,204
| Closed | -$155K | – | 2362 |
|
|
2024
Q1 | $155K | Sell |
34,204
-76,984
| -69% | -$349K | ﹤0.01% | 2213 |
|
|
2023
Q4 | $635K | Buy |
111,188
+18,217
| +20% | +$104K | ﹤0.01% | 1908 |
|
|
2023
Q3 | $428K | Buy |
92,971
+20,450
| +28% | +$94.1K | ﹤0.01% | 1983 |
|
|
2023
Q2 | $468K | Buy |
72,521
+24,473
| +51% | +$158K | ﹤0.01% | 1971 |
|
|
2023
Q1 | $362K | Sell |
48,048
-983
| -2% | -$7.41K | ﹤0.01% | 2046 |
|
|
2022
Q4 | $497K | Buy |
49,031
+23,906
| +95% | +$242K | ﹤0.01% | 1977 |
|
|
2022
Q3 | $248K | Buy |
25,125
+5,222
| +26% | +$51.5K | ﹤0.01% | 2146 |
|
|
2022
Q2 | $212K | Buy |
+19,903
| New | +$212K | ﹤0.01% | 2286 |
|